CLIENT LOGIN
BRANCH LOGIN
OLD CLIENT LOGIN
OLD BRANCH LOGIN
X
AFFLUENCE
About Us
WEB LOGIN
ONLINE TRADING
BACK OFFICE
DOWNLOADS
BANK ACCOUNTS
CAREERS
CONTACT US
CORPORATE CONSULTANCY
Wealth Management
Institutional Broking
Investment Banking
Financial Planning
Equity
DERIVATIVES
COMMODITY
CURRENCY DERIVATIVES
MUTUAL FUNDS
INSURANCE
NRI SERVICES
REAL ESTATE
RESEARCH
Equity
DERIVATIVES
COMMODITY
CURRENCY DERIVATIVES
MUTUAL FUNDS
INSURANCE
NRI SERVICES
REAL ESTATE
RESEARCH
Equity
NAV
Go
Corporate Announcements
Home
| Market Info | Company Profile | Corporate Announcements
Equity
Price Analysis
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Highs & Lows
Advances & Declines
Weightage
5 Day's Up & Down
Historical Returns
Heat Map
Volume Analysis
Most Active
Block Deals
Bulk Deals
Highest / Lowest Delivery
Index Analysis
Live Indices
Price Shockers
Volume Shockers
Delivery Shockers
Rising VDP
Rise Volume, Delivery & Fall in Price
News Analysis
Hot Stocks
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Opening Bell
Midday Review
Closing Bell
Current Affairs & Politics
Global Markets
Mutual Fund News
Market Commentary
Corporate Action
BSE Announcements
Book Closure
Board Meetings
Bonus Issues
Right Issues
Split of Face Value
Dividend Details
Delisted Companies
Change of Name
Other Market
FII Investments
DII Investments
Indices
World Indices
ADR Prices
Forex
Company Profile
Smart Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Share Price
MF Holdings
Price Charts
Company News
Company Chart
Cash Flow
Share Holdings
Deliverable Volume
Historical Volume
Directors Report
Peer Comparison
Board Meetings
Corporate Announcements
Book Closure
Bonus Issues
AGM
Company List
Nath Bio-Genes (India) Ltd.
BSE CODE: 537291
|
NSE CODE:
NATHBIOGEN
|
ISIN CODE : INE448G01010
|
22-Nov-2024 Hrs IST
BSE
NSE
Rs.
173.75
1.7
( 0.99% )
Prev Close (
Rs.
)
172.05
Open (
Rs.
)
180.00
High (
Rs.
)
180.00
Low (
Rs.
)
172.30
Volume
565
Week Avg.Volume
3792
52 WK High-Low Range(
Rs.
)
167.5
264.5
BSE
NSE
Rs.
173.62
1.27
( 0.74% )
Prev Close (
Rs.
)
172.35
Open (
Rs.
)
175.41
High (
Rs.
)
179.90
Low (
Rs.
)
171.48
Volume
9464
Week Avg.Volume
15437
52 WK High-Low Range(
Rs.
)
167.15
264.31
BSE
Rs.
173.75
1.7
( 0.99% )
Prev Close (
Rs.
)
172.05
Open (
Rs.
)
180.00
High (
Rs.
)
180.00
Low (
Rs.
)
172.30
Volume
565
Week Avg.Volume
3792
52 WK High-Low Range(
Rs.
)
167.5
264.5
NSE
173.62
1.27
( 0.74% )
Prev Close (
Rs.
)
172.35
Open (
Rs.
)
175.41
High (
Rs.
)
179.90
Low (
Rs.
)
171.48
Volume
9464
Week Avg.Volume
15437
52 WK High-Low Range(
Rs.
)
14-05-2024
Analysts/Institutional Investor Meet/Con. Call Updates
.......
Nath Bio-Genes (India) Limited has informed the Exchange about Transcript
Close
09-05-2024
Loss of Share Certificates
.......
Nath Bio-Genes (India) Limited has informed the Exchange about Loss of Share Certificates
Close
09-05-2024
Loss/Duplicate-Share Certificate-XBRL
.......
NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Loss of share certificates
Close
09-05-2024
Updates
.......
Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Audio Recordings of Conference Call'.
Close
08-05-2024
Dividend
.......
Nath Bio-Genes (India) Limited has informed the Exchange that Board of Directors at its meeting held on May 08, 2024, recommended Final Dividend of Rs. 2 per equity share.
Close
08-05-2024
Financial Result Updates
.......
Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024.
Close
08-05-2024
Investor Presentation
.......
Nath Bio-Genes (India) Limited has informed the Exchange about Investor Presentation
Close
08-05-2024
Outcome of Board Meeting-XBRL
.......
NATH BIO-GENES (INDIA) LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 08-May-2024 for Dividend
Close
08-05-2024
Related Party Transactions
.......
Nath Bio-Genes (India) Limited has informed the Exchange about related Party Transactions
Close
07-05-2024
Disclosure under SEBI Takeover Regulations
.......
Nath Bio-Genes (India) Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Close
Page
1
of
7
Prev
||
Next